HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Youngjoo Lee Selected Research
Youngjoo Lee Research Topics
Disease
13
Lung Neoplasms (Lung Cancer)
03/2022 - 03/2012
13
Neoplasms (Cancer)
12/2021 - 07/2014
11
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 01/2015
4
Disease Progression
02/2022 - 07/2014
4
Breast Neoplasms (Breast Cancer)
07/2019 - 01/2009
4
Neoplasm Metastasis (Metastasis)
10/2017 - 03/2011
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2022 - 01/2021
3
Brain Neoplasms (Brain Tumor)
01/2022 - 01/2017
3
Adenocarcinoma of Lung
11/2020 - 12/2012
3
Hypoxia (Hypoxemia)
02/2012 - 03/2011
2
Adenocarcinoma
04/2022 - 10/2013
2
Pneumonia (Pneumonitis)
01/2022 - 01/2021
2
Body Weight (Weight, Body)
01/2018 - 01/2016
2
Exanthema (Rash)
10/2017 - 03/2012
2
Inflammation (Inflammations)
01/2016 - 06/2012
1
Esophageal Neoplasms (Esophageal Cancer)
04/2022
1
Hypertrophy
01/2022
1
Growth Disorders
01/2022
1
Gastritis
01/2022
1
Lymphatic Metastasis
01/2021
1
Hyperinsulinism (Hyperinsulinemia)
01/2021
1
Meningeal Carcinomatosis
01/2021
1
Organizing Pneumonia
01/2020
1
Infections
12/2019
1
Neuroblastoma
01/2019
1
Carcinogenesis
01/2019
1
Colorectal Neoplasms (Colorectal Cancer)
11/2018
1
Hyperlipidemias (Hyperlipidemia)
03/2017
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2017
1
Neurocysticercosis
01/2017
1
Obesity
01/2016
1
Type 2 Diabetes Mellitus (MODY)
01/2016
1
Dyslipidemias (Dyslipidemia)
01/2016
1
Angiomyolipoma
09/2015
1
Nocardia Infections
12/2014
Drug/Important Bio-Agent (IBA)
9
Tyrosine Kinase Inhibitors
IBA
11/2020 - 03/2012
7
Gefitinib (Iressa)
FDA Link
03/2022 - 03/2012
6
ErbB Receptors (EGF Receptor)
IBA
01/2017 - 03/2012
5
Pharmaceutical Preparations
IBA
01/2022 - 03/2014
4
Immune Checkpoint Inhibitors
IBA
02/2022 - 12/2020
4
Cisplatin (Platino)
FDA Link
Generic
11/2020 - 12/2012
3
Biomarkers (Surrogate Marker)
IBA
05/2021 - 12/2012
3
Glucose (Dextrose)
FDA Link
Generic
01/2021 - 01/2016
3
Erlotinib Hydrochloride (CP 358,774)
FDA Link
10/2017 - 03/2012
2
pembrolizumab
IBA
12/2021 - 12/2020
2
DNA (Deoxyribonucleic Acid)
IBA
10/2021 - 01/2015
2
Metformin (Glucophage)
FDA Link
Generic
01/2021 - 01/2018
2
Pemetrexed (MTA)
FDA Link
01/2021 - 11/2020
2
Hormones (Hormone)
IBA
07/2019 - 04/2011
2
Gemcitabine
FDA Link
10/2013 - 12/2012
2
Iron
IBA
06/2012 - 06/2011
2
Estrogen Receptors
IBA
04/2011 - 03/2011
2
Messenger RNA (mRNA)
IBA
04/2011 - 01/2009
1
Circulating Tumor DNA
IBA
03/2022
1
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
01/2022
1
lazertinib
IBA
01/2022
1
Complement C7 (Complement 7)
IBA
12/2021
1
capmatinib
IBA
10/2021
1
Phosphotransferases (Kinase)
IBA
10/2021
1
Glial Fibrillary Acidic Protein
IBA
05/2021
1
Platinum
IBA
01/2021
1
Insulin (Novolin)
FDA Link
01/2021
1
Cell-Free Nucleic Acids
IBA
01/2021
1
Thymidylate Synthase
IBA
01/2021
1
Cytotoxins (Cytolysins)
IBA
01/2021
1
Cobalt
IBA
01/2021
1
Fluorine
IBA
12/2020
1
Nivolumab
IBA
12/2020
1
ceritinib
IBA
01/2020
1
Anti-Bacterial Agents (Antibiotics)
IBA
12/2019
1
human ERBB2 protein
IBA
07/2019
1
Trastuzumab (Herceptin)
FDA Link
07/2019
1
Apoptosis Regulatory Proteins
IBA
01/2019
1
Small Interfering RNA (siRNA)
IBA
01/2019
1
IDF-11774
IBA
11/2018
1
Vacuolar Proton-Translocating ATPases (V-Type ATPase)
IBA
11/2018
1
Lipids
IBA
01/2018
1
Simvastatin (Zocor)
FDA Link
Generic
10/2017
1
Irinotecan (Camptosar)
FDA Link
Generic
10/2017
1
Afatinib
IBA
10/2017
1
Cholesterol
IBA
03/2017
1
Anaplastic Lymphoma Kinase
IBA
01/2017
1
Crizotinib
IBA
01/2017
1
HM781-36B
IBA
01/2017
1
Atorvastatin (Lipitor)
FDA Link
01/2016
1
Cytokines
IBA
01/2016
1
Therapeutic Uses
IBA
01/2016
1
Rosuvastatin Calcium (Crestor)
FDA Link
01/2016
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2016
1
Steroids
IBA
12/2014
Therapy/Procedure
10
Therapeutics
02/2022 - 03/2012
7
Drug Therapy (Chemotherapy)
01/2021 - 12/2012
2
Proton Therapy
04/2022 - 01/2021
2
Radiotherapy
04/2022 - 01/2021
2
Chemoradiotherapy
04/2022 - 10/2017
2
Aftercare (After-Treatment)
01/2021 - 07/2014
1
Neoadjuvant Therapy
04/2022
1
Fecal Microbiota Transplantation
01/2018
1
Cranial Irradiation
01/2017
1
Nephrectomy
09/2015